Drugs / PomWonderful Juice
last change Sep 2005 re-read 3 minutes ago

PomWonderful Juice

targets ACE via inhibition

Developed for
coronary artery disorder
Investigated by
Radiant Research · Roll International Corporation

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00728299 Sep 2003 → Sep 2005 coronary artery disorder Radiant Research Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PomWonderful Juice ClinicalTrials.gov intervention name — accepted as the source's own label NCT00728299 ↗
Action Inhibit “pomegranate juice had an angiotensin converting enzyme (ACE)-inhibitory effect” NCT00728299 ↗
Target ACE “pomegranate juice had an angiotensin converting enzyme (ACE)-inhibitory effect” NCT00728299 ↗